Unstandardized coefficient | Bootstrap SE | P value | 95% CI | ||
LL | UL | ||||
→FM survey criteria score | |||||
Child abuse only | 2.92 | 0.37 | < 0.001 | 2.198 | 3.647 |
Adult abuse only | 3.13 | 0.66 | < 0.001 | 1.829 | 4.427 |
Cumulative abuse | 5.91 | 0.62 | < 0.001 | 4.693 | 7.129 |
Age | −0.03 | 0.01 | < 0.001 | −0.047 | −0.019 |
Female | 0.99 | 0.22 | < 0.001 | 0.561 | 1.412 |
→Pain catastrophizing | |||||
Child abuse only | 3.53 | 0.60 | < 0.001 | 2.363 | 4.699 |
Adult abuse only | 2.94 | 1.08 | 0.006 | 0.823 | 5.055 |
Cumulative abuse | 3.66 | 0.99 | < 0.001 | 1.733 | 5.596 |
Age | −0.10 | 0.01 | < 0.001 | −0.122 | −0.076 |
Female | −0.28 | 0.36 | 0.440 | −0.988 | 0.430 |
→Sum of pain medication side effects | |||||
FM survey criteria score | 0.12 | 0.01 | < 0.001 | 0.100 | 0.140 |
Pain catastrophizing | 0.02 | 0.01 | < 0.001 | 0.011 | 0.032 |
Age | 0.01 | 0.003 | 0.027 | 0.001 | 0.011 |
Female | 0.15 | 0.08 | 0.079 | −0.017 | 0.313 |
Covariate and lifetime abuse history covariance | |||||
FM survey criteria score↔pain catastrophizing | 18.82 | 1.09 | < 0.001 | 16.680 | 20.957 |
Child abuse only↔adult abuse only | −0.003 | 0.0004 | < 0.001 | −0.004 | −0.002 |
Child abuse only↔cumulative abuse | −0.002 | 0.0003 | < 0.001 | −0.003 | −0.002 |
Child abuse only↔age | −0.33 | 0.08 | < 0.001 | −0.486 | −0.184 |
Child abuse only↔female | 0.02 | 0.003 | < 0.001 | 0.016 | 0.026 |
Adult abuse only↔cumulative abuse | −0.001 | 0.0001 | < 0.001 | −0.001 | −0.0005 |
Adult abuse only↔age | −0.05 | 0.04 | 0.133 | −0.126 | 0.017 |
Adult abuse only↔female | 0.01 | 0.001 | < 0.001 | 0.007 | 0.012 |
Cumulative abuse↔age | −0.09 | 0.03 | 0.003 | −0.153 | −0.031 |
Cumulative abuse↔female | 0.01 | 0.001 | < 0.001 | 0.007 | 0.011 |
Age↔female | −0.21 | 0.14 | 0.122 | −0.486 | 0.057 |
Bold faced results are significant at p<0.05.
FM, fibromyalgia; LL, lower limit; UL, upper limit.